These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2503348)

  • 1. Muromonab CD3. A review of its pharmacology and therapeutic potential.
    Todd PA; Brogden RN
    Drugs; 1989 Jun; 37(6):871-99. PubMed ID: 2503348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection.
    Wilde MI; Goa KL
    Drugs; 1996 May; 51(5):865-94. PubMed ID: 8861551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunologic monitoring with Orthoclone OKT3 therapy.
    Schroeder TJ; First MR; Hurtubise PE; Marmer DJ; Martin DM; Mansour ME; Melvin DB
    J Heart Transplant; 1989; 8(5):371-80. PubMed ID: 2529358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monoclonal antibodies in renal transplantation: a review.
    Parlevliet KJ; Schellekens PT
    Transpl Int; 1992 Sep; 5(4):234-46. PubMed ID: 1418316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with Muromonab-CD3 monoclonal antibody (OKT3) in heart transplantation.
    Macris MP; Frazier OH; Lammermeier D; Radovancevic B; Duncan JM
    J Heart Transplant; 1989; 8(4):281-7. PubMed ID: 2504894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversing cardiac transplant rejection with Orthoclone OKT3.
    Dault LA; Nagy CS; Collins JA
    Am J Nurs; 1989 Jul; 89(7):953-5. PubMed ID: 2500020
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection.
    Georgitis JW; Browning MC; Steiner D; Lorentz WB
    Ann Allergy; 1991 Apr; 66(4):343-7. PubMed ID: 1901692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with Orthoclone OKT3 monoclonal antibody in liver transplantation.
    Gordon RD; Tzakis AG; Iwatsuki S; Todo S; Esquivel CO; Marsh JW; Stieber A; Makowka L; Starzl TE
    Am J Kidney Dis; 1988 Feb; 11(2):141-4. PubMed ID: 3124609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of Orthoclone OKT3 monoclonal antibody to reverse acute renal allograft rejection unresponsive to treatment with conventional immunosuppressive regimens.
    Monaco A; Goldstein G; Barnes L
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):28-31. PubMed ID: 3105137
    [No Abstract]   [Full Text] [Related]  

  • 10. [Orthoclone OKT3 (Muromonab CD3)--the indications for and manner of its use. Side effects and their prevention].
    Filev A; Kumanov Kh; Slavov Ch; Tsvetkov M
    Khirurgiia (Sofiia); 1989; 42(6):80-2. PubMed ID: 2517512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthoclone OKT3 as rescue treatment for steroid-resistant and recurrent acute rejection in clinical renal transplantation.
    Tvedegaard E; Olgaard K
    Transplant Proc; 1990 Feb; 22(1):217-8. PubMed ID: 2106738
    [No Abstract]   [Full Text] [Related]  

  • 12. Orthoclone OKT3 treatment of acute renal allograft rejection.
    Friedman J; Barnes L; Sheahan M; Tsai H; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 2):46. PubMed ID: 3105144
    [No Abstract]   [Full Text] [Related]  

  • 13. Orthoclone OKT3 monoclonal antibody reversal of hepatic and cardiac allograft rejection unresponsive to conventional immunosuppressive treatments.
    Kremer AB; Barnes L; Hirsch RL; Goldstein G
    Transplant Proc; 1987 Apr; 19(2 Suppl 1):54-7. PubMed ID: 3105141
    [No Abstract]   [Full Text] [Related]  

  • 14. OKT 3: nursing considerations for use in acute renal transplant rejection.
    Trusler LA
    ANNA J; 1990 Aug; 17(4):299-303. PubMed ID: 2118750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of Orthoclone OKT3 as treatment of acute renal allograft rejection and as first-line therapy in kidney transplantation.
    Winde G; Dietl KH; Raidt H; Buchholz B; Lison AE; Bünte H
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):87-9. PubMed ID: 3140453
    [No Abstract]   [Full Text] [Related]  

  • 16. Orthoclone OKT3 as first-line therapy in acute renal allograft rejection.
    Strate M; Jørgensen KA; Rohr N; Elbirk A; Svendsen V; Birkeland SA
    Transplant Proc; 1990 Feb; 22(1):219-20. PubMed ID: 2106739
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute renal allograft rejection: the role of monoclonal antibodies in treatment: experience with orthoclonal anti-T3 cell antibody.
    McLigeyo SO; Notghi A; Anderton JL; Dick J
    East Afr Med J; 1990 Sep; 67(9):667-73. PubMed ID: 2123786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with OKT3 and cyclosporine for acute allograft rejection.
    Schulak JA; Mayes JT; Hricik DE
    Transplant Proc; 1991 Aug; 23(4):2119-22. PubMed ID: 1908150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muromonab-CD3 and antithymocyte globulin in renal transplantation.
    Burk ML; Matuszewski KA
    Ann Pharmacother; 1997 Nov; 31(11):1370-7. PubMed ID: 9391693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prophylactic use of Orthoclone OKT3 in kidney and heart transplantation.
    Weimar W; Baumgartner D; Hendriks GF; Hesse CJ; Balk AH; Simoons ML; Bos E
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):96-100. PubMed ID: 3140455
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.